Al B. Benson
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 234
- Colorectal Cancer Treatments and Studies 112
- Colorectal Cancer Surgical Treatments 61
- Pancreatic and Hepatic Oncology Research 60
- Hepatology 54
- Hepatocellular Carcinoma Treatment and Prognosis 53
- Co-authors
- Paul J. Catalano (34 shared papers)Daniel G. Haller (22 shared papers)Peter James O'Dwyer (20 shared papers)Mary F. Mulcahy (65 shared papers)Riad Salem (33 shared papers)Robert J. Mayer (33 shared papers)Edith Peterson Mitchell (11 shared papers)John Smyth Macdonald (14 shared papers)
- Journals
- Journal of Clinical Oncology (78 papers)Journal of the National Comprehensive Cancer Network (65 papers)Cancer (26 papers)The Oncologist (22 papers)International Journal of Radiation Oncology*Biology*Physics (18 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Al B. Benson
484 papers receiving 57.9k citations
Al B. Benson's Hit Papers
Peers
Comparison fields: 5 of 176
- Hepatology 8.8k
- Oncology 28.3k
- Cancer Research 7.1k
- Pulmonary and Respiratory Medicine 10.0k
- Pathology and Forensic Medicine 5.2k
Countries citing papers authored by Al B. Benson
This map shows the geographic impact of Al B. Benson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Al B. Benson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Al B. Benson more than expected).
Fields of papers citing papers by Al B. Benson
This network shows the impact of papers produced by Al B. Benson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Al B. Benson. The network helps show where Al B. Benson may publish in the future.
Co-authors
The 25 scholars most cited alongside Al B. Benson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 499 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Hit paper breakdown → | 2016 | 2659 |
| 2 | Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors Hit paper breakdown → | 2017 | 2506 |
| 3 | Hepatobiliary Cancers Hit paper breakdown → | 2009 | 1985 |
| 4 | Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Hit paper breakdown → | 2007 | 1887 |
| 5 | American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Hit paper breakdown → | 2005 | 1499 |
| 6 | American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer Hit paper breakdown → | 2004 | 1180 |
| 7 | Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2021 | 1161 |
| 8 | Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2017 | 1086 |
| 9 | Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Hit paper breakdown → | 2018 | 1056 |
| 10 | Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2021 | 920 |
| 11 | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer Hit paper breakdown → | 2020 | 872 |
| 12 | Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes Hit paper breakdown → | 2009 | 861 |
| 13 | Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2014 | 827 |
| 14 | Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2017 | 815 |
| 15 | NCCN Guidelines Insights: Colon Cancer, Version 2.2018 Hit paper breakdown → | 2018 | 748 |
| 16 | Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2018 | 738 |
| 17 | Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2021 | 713 |
| 18 | Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer Hit paper breakdown → | 2001 | 711 |
| 19 | Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer Hit paper breakdown → | 2017 | 711 |
| 20 | Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial Hit paper breakdown → | 2011 | 683 |
About Al B. Benson
Al B. Benson is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 499 papers that have together received 59.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (112 papers), Colorectal Cancer Surgical Treatments (61 papers), Pancreatic and Hepatic Oncology Research (60 papers), Gastric Cancer Management and Outcomes (58 papers), Hepatocellular Carcinoma Treatment and Prognosis (53 papers), Colorectal and Anal Carcinomas (42 papers), Neuroendocrine Tumor Research Advances (41 papers) and Genetic factors in colorectal cancer (39 papers). The work is most often cited by research in Hepatology (8.8k citations), Oncology (28.3k citations), Cancer Research (7.1k citations), Pulmonary and Respiratory Medicine (10.0k citations) and Pathology and Forensic Medicine (5.2k citations). Al B. Benson has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Paul J. Catalano, Daniel G. Haller, Peter James O'Dwyer, Mary F. Mulcahy, Riad Salem, Robert J. Mayer, Edith Peterson Mitchell, John Smyth Macdonald, Steven R. Alberts and Neal J. Meropol. Their work appears in journals such as Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network, Cancer, The Oncologist and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.